PubMed COVID-19 Clinical Care

No abstract

This paper aims to understand the critical areas for sustainable behavioural change on a university campus in order to achieve the net zero‑carbon ambition pre- and post-COVID-19 pandemic recovery. For this purpose, the current empirical study is the

In the period of the corona virus disease 2019 (COVID-19) outbreak, an alcohol-based hand sanitizer is one of the most in-demand products for disinfection purposes. Two major concerns are adulteration of methanol, which causes toxicity to human

Most studies on the long-term effects of SARS-CoV-2 infection have been retrospective, have lacked an uninfected comparison group, and have focussed on the prevalence of individual symptoms, resulting in different estimates of prevalence. Recognizing

BACKGROUND The COVID-19 epidemic has caused a huge amount of occupational stress among emergency department (ED) nurses. They are not only at high risk of infection, but they are also more likely to experience mental health problems. This study aimed

CONCLUSIONS: Vaccination and previous infection leave a clear serological imprint that is focused on the variant-specific antigen. Importantly, both bivalent vaccines induce high levels of omicron variant-specific antibodies, suggesting broad cross

CONCLUSION: Patients with PsO and patients with PsA initiating apremilast via telehealth or in-person during the COVID-19 pandemic had similar medication adherence and persistence during the 6-month follow-up period. These data suggest that patients

Estimating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) -specific immunoglobulin G (IgG) immunoglobulin M (IgM) antibodies are increasingly important for tracking the spread of infection and defining herd immunity barrier and

SARS-CoV-2, the causative agent of COVID-19, primarily affects the epithelial compartment in the upper and lower airways. There is evidence that the microvasculature in both the pulmonary and extrapulmonary systems is a major target of SARS-CoV-2

CONCLUSIONS: The existing evidence and panel consensus do not suggest a major departure from the management of arterial thrombosis as per pre-COVID-19 recommendations. Data on the optimal strategies for prevention and management of arterial